VRB-101
EVOLVE-2
Verdiva Bio Dev Limited · Phase 2 · Completed · Enrollment 206
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Schedule A: VRB-101 (Active Arm 1) | Obesity or overweight | n/r | n/r | n/r | n/r |
| Schedule A: VRB-101 (Active Arm 2) | Obesity or overweight | n/r | n/r | n/r | n/r |
| Schedule A: VRB-101 (Active Arm 3) | Obesity or overweight | n/r | n/r | n/r | n/r |
| Schedule B: VRB-101 (Active Arm 4) | Obesity or overweight | n/r | n/r | n/r | n/r |
| Schedule B: VRB-101 (Active Arm 5) | Obesity or overweight | n/r | n/r | n/r | n/r |
| Pooled Placebo | Obesity or overweight | n/r | n/r | n/r | n/r |